Crossref
Commentary on Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement
Oncology in Clinical Practice · 2024
DOI: 10.5603/ocp.100207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology in Clinical Practice, 2024. Verfasst von Maciej Krzakowski.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Krzakowski, M. (2024). Commentary on Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement. Oncology in Clinical Practice. https://doi.org/10.5603/ocp.100207
Vancouver
Krzakowski M. Commentary on Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement. Oncology in Clinical Practice. 2024. doi:10.5603/ocp.100207
BibTeX
@article{Krzakowski2024,
author = {Krzakowski, Maciej},
title = {Commentary on Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement},
journal = {Oncology in Clinical Practice},
year = {2024},
doi = {10.5603/ocp.100207}
}
EUVIMED